Key facts
- MediView’s last known valuation is $93.5M (Jan 2025).
- It has raised $43.9M; the latest was Later Stage VC ($14.0M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, JobsOhio Ventures, Mayo Clinic Ventures, Echo Investment Capital, Edge Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for MediView
- ·The full record, as it builds
Funding rounds
No funding rounds for MediView are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MediView
Developer of an extended reality surgical navigation technology designed to maximize the accuracy and efficacy of cancer therapies. The company's technology involves real-time, fused-holographic visualization and facilitates surgical navigation and telehealth with augmented reality 3D (three-dimensional) visualization and remote collaboration, enabling healthcare providers to optimally examine a patient using a hologram instead of a conventional 2D (two-dimensional) display screen.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2017
- Employees
- 44
- Website
- mediview.com/
- Ownership
- Privately Held (backing)
MediView doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediView shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediView in its N-PORT filings yet. We sweep new filings monthly.